Across the nation, healthcare providers are thoroughly adjusting their approaches to BZD administration following the release of new brand name for Benzodiazepines in Cnada guidelines. These standards aim to reduce the dangers associated with long-term use and reliance, stressing the critical need of comprehensive patient evaluations and exploring